These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37922713)

  • 1. Successful use of intravenous and oral levetiracetam in a goat to control refractory seizures secondary to suspected polioencephalomalacia.
    Stapley ED; Breuer RM; Burton AJ
    J Am Vet Med Assoc; 2024 Feb; 262(2):1-3. PubMed ID: 37922713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
    Dooley M; Plosker GL
    Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam for treatment of neonatal seizures.
    Abend NS; Gutierrez-Colina AM; Monk HM; Dlugos DJ; Clancy RR
    J Child Neurol; 2011 Apr; 26(4):465-70. PubMed ID: 21233461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of Subcutaneous Levetiracetam in Palliative Care.
    Gaviria-Carrillo M; Mora-Muñoz L; Diaz-Forero AF; Vargas-Osorio J; Torres-Ballesteros V; Estrada J; Vélez Van Meerbeke A; Rodríguez JH
    Med Princ Pract; 2023; 32(1):90-95. PubMed ID: 36731437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Köle MT; Sager SG; Zeynel H; Çağ Y; Akın Y
    Childs Nerv Syst; 2022 Jul; 38(7):1357-1364. PubMed ID: 35501510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on levetiracetam in epilepsy.
    Lyseng-Williamson KA
    CNS Drugs; 2011 Oct; 25(10):901-5. PubMed ID: 21936590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Single Oral Dose Extended-Release Levetiracetam in Healthy Cats.
    Barnard L; Barnes Heller H; Boothe DM
    J Vet Intern Med; 2018 Jan; 32(1):348-351. PubMed ID: 29114943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
    Spencer DD; Jacobi J; Juenke JM; Fleck JD; Kays MB
    Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.
    Abend NS; Monk HM; Licht DJ; Dlugos DJ
    Pediatr Crit Care Med; 2009 Jul; 10(4):505-10. PubMed ID: 19325512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial.
    Glauser TA; Pellock JM; Bebin EM; Fountain NB; Ritter FJ; Jensen CM; Shields WD
    Epilepsia; 2002 May; 43(5):518-24. PubMed ID: 12027913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.
    Hardy BT; Patterson EE; Cloyd JM; Hardy RM; Leppik IE
    J Vet Intern Med; 2012; 26(2):334-40. PubMed ID: 22295898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam for the Treatment of Seizures in Neonatal Hypoxic Ischemic Encephalopathy.
    Venkatesan C; Young S; Schapiro M; Thomas C
    J Child Neurol; 2017 Feb; 32(2):210-214. PubMed ID: 27872177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam.
    Nash EM; Sangha KS
    Am J Health Syst Pharm; 2001 Jul; 58(13):1195-9. PubMed ID: 11449876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.
    Lee YJ; Kim T; Bae SH; Kim YH; Han JH; Yun CH; Kim CY
    CNS Drugs; 2013 Sep; 27(9):753-9. PubMed ID: 23921717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Dose Levetiracetam for Neonatal Seizures: A Retrospective Review.
    Hnaini M; Darwich M; Koleilat N; Jaafar F; Hanneyan S; Rahal S; Mikati IE; Shbarou RM; Nabout R; Maalouf FI; Obeid M
    Seizure; 2020 Nov; 82():7-11. PubMed ID: 32950862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of levetiracetam as an anti-epileptic drug.
    Jain KK
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.